** Shares of drug distributor McKesson MCK.N rise 4.5% to $721
** MCK late on Thursday forecast fiscal year 2026 profit largely above estimates
** Company said it is planning to spin off its medical-surgical solutions unit into an independent company to focus on its core drug distribution business
** Expects per-share profit in the range of $36.75 to $37.55 for 2026, compared with analysts' average estimate of $36.76 -data compiled by LSEG
** Posted Q4 earnings of $10.12 per share vs estimate of $9.82 per share
** Including session's moves, stock up 21.1% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.